Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Stay tuned for the update

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Jun 12, 2022 10:56am

156 Views

Post# 34750000

RE:RE:RE:RE:RE:RE:Stay tuned for the update

My first source of information seems to be outdated as tells me that $5 USD is required as the initial bid price for the stock:

https://www.findlaw.com/smallbusiness/business-finances/markets-and-listing-requirements.html

Another source seems to be up to date and publish a requirement of $4 USD:

https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/

The stock price can trade below that level, but below $1 USD would put the company in trouble with NASDAQ.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario